Skip to content

Clinical trials

Hepatitis C trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: Belgium Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20075
20083
20097
20109
201113
201212
20131
20143
20155
20161
20177
20182
20193
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Terminated4
Unknown status2
Enrolling by invitation1
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences11
Tibotec Pharmaceuticals, Ireland9
Janssen R&D Ireland8
AbbVie6
Debiopharm International SA5
Bristol-Myers Squibb4
GlaxoSmithKline4
Hasselt University4
Pfizer4
Atea Pharmaceuticals, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C76
Hepatitis C, Chronic20
Fibrosis5
Acquired Immunodeficiency Syndrome4
Hepatitis4
Hepatitis B4
HIV Infections3
Liver Diseases3
Infections2
Acidosis, Lactic1

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.